Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
What you eat could impact your brain and memory
AMES, Iowa - You may be familiar with the saying, "You are what you eat," but did you know the food you eat could impact your memory?Auriel Willette, assistant professor, and his team of res...
Pfizer's Xtandi blows by Johnson & Johnson's Erleada with hot start in new prostate cancer field
Pfizer's Xtandi pulled in $189 million in fourth-quarter.
Samsung BioLogics sees sales rise but profit fall as it continues expansion
Samsung BioLogics built three biologics manufacturing plants in South Korea in seven years.
£1.5million investment in Parkinson’s drug discovery
Parkinson’s UK says it intends to invest a further £1.
Pfizer inaugurates pay-for-performance in China with money-back Ibrance deal
Lately, every day seems to bring new talk about "innovative" payment models for expensive drugs in the U.
Novo Nordisk stockpiling over double usual amount ahead of Brexit
Novo Nordisk says it has planned for all future ‘no-deal’ Brexit contingencies, including doubling UK stock to 16 weeks (around four months of supply), which will be in place by the end of...
Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
Cambridge, Mass.
Global medicine spend forecast to exceed $1.5 trillion by 2023
A new report containing the latest predictions for the global pharmaceutical market has found that global spending on medicines is set to exceed $1.
Biogen beats estimates on multiple sclerosis drugs sales
(Reuters) - Biogen Inc beat analysts’ estimates for fourth-quarter profit and revenue on Tuesday, buoyed by higher sales of its top-selling multiple sclerosis drugs, and forecast full-year p...
Israeli cabinet approves law to allow medical cannabis exports
JERUSALEM (Reuters) - Israel’s cabinet approved on Sunday a law to allow exports of medical cannabis in a move expected to boost state revenues and the agriculture sector, and which frustrat...
AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) - First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Previously Untreated Patien
NORTH CHICAGO, Ill.
Alexion Announces Positive Top-Line Results From Phase 3 Study Of ULTOMIRIS™ (Ravulizumab-Cwvz) In Complement Inhibitor-Naïve Patients With Atypical Hemolytic Uremic Syndrome (AHUS)
BOSTON--(BUSINESS WIRE) -- Jan.
392
393
394
395
396
397
398
399
400
